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Abstract
The central nervous system has the capacity to activate profound neuroprotection following sub-lethal stress in a process
termed preconditioning. To gain insight into this potent survival response we developed a functional cloning strategy that
identified 31 putative neuroprotective genes of which 28 were confirmed to provide protection against oxygen-glucose
deprivation (OGD) or excitotoxic exposure to N-methyl-D-aspartate (NMDA) in primary rat cortical neurons. These results
reveal that the brain possesses a wide and diverse repertoire of neuroprotective genes. Further characterization of these
and other protective signals could provide new treatment opportunities for neurological injury from ischemia or
neurodegenerative disease.
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Introduction
In response to sub-lethal insults, the central nervous system has
the capacity to protect itself from subsequent serious injury by
transiently activating the expression of survival networks. This
form of neuronal plasticity, termed preconditioning is dependent
on new gene transcription and protein translation [1]. Diverse
stimuli ranging from spreading depression, transient ischemic
episodes, hypoxia, anoxia, exposure to glutamate excitotoxins and
cytokines can induce preconditioning. Gene activation and
repression set in motion by these preconditioning stimuli is
temporally specific and induces diverse families of pro-survival
genes that enhance the brain’s resistance to injury [1].
The nature of the preconditioning stimulus determines the
transduction pathway that ultimately leads to post-translational
modifications and/or activation of transcriptional responses that
drive the genomic survival response. A number of transcription
factors are thought to participate in the process and include cAMP
response element-binding protein (CREB), myocyte enhancer
factor 2 (MEF2), nuclear factor kB (NFkB), hypoxia-inducible
factor (HIF) and others. While the neuroprotective molecules and
networks that these events trigger are largely unknown, a
consistent observation is that the brain’s response to these stressors
can subsequently provide profound protection against subsequent
lethal injury [1].
Since this neuroprotective network requires new gene tran-
scription and protein translation, it is highly suited for gene
screening strategies. To gain insight into this neuroprotection we
generated a cDNA library from preconditioned cortical neurons
and conducted a functional cloning screen for protective
molecules. Here we describe the results of this screen and the
identification of 31 neuroprotective genes of diverse function.
Results
Establishment of Preconditioning
Preconditioning that elicits survival sustainable for several days
requires new gene transcription and protein translation. To
identify the time point at which these genes are expressed and thus
the optimal time point to harvest RNA to generate the cDNA
library a time course for development of preconditioning was
conducted. Cortical cultures were exposed to a preconditioning
condition of 15 min OGD and then returned to growth media. At
the indicated time points the cultures were challenged with a lethal
exposure of 90 min OGD and 24 hrs later cell viability was
evaluated. These experiments reveal that the protective effects of
OGD preconditioning were clear and reproducible as early as
16 hr after OGD preconditioning (Fig. 1A).
Conditions for functional screening in mouse fibroblasts
In the nervous system NMDA excitotoxicity is mediated largely
by parthanatos, poly (ADP-ribose) polymerase 1 (PARP-1)
dependent cell death [2,3]. Since the functional screening strategy
employed here requires dividing cells, it cannot be conducted in
postmitotic neuronal cultures. Therefore cell death conditions in
mouse fibroblasts that are consistent with PARthanatos, in which
cells die in a PARP-1 dependent, caspase independent cell death
pathway were developed. To reduce the number of false-positive
surviving cells, conditions that killed 100% of the fibroblasts
needed to be identified. 2-methyl-1,4-napthoquinone (menadione)
is commonly used to induce oxidative stress and can kill cells
through parthanatos. Exposure for 10 min to 175 mM menadione
was found to kill 100% of wild-type fibroblasts, but only 55%
PARP-1 knockout fibroblasts (Fig. 1B). This cell death cannot be
blocked by the caspase inhibitors, ZVAD (100 mM) or BAF
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exposed to a relatively non-selective protein kinase inhibitor,
staurosporine (500 nM, 24 h) die in a caspase-dependent manner
as ZVAD (100 mM) or BAF (50 mM) protect against staurosporine
induced cell death (Fig. 1B). Therefore, exposure to menadione
(175 mM, 10 min) kills cells via parthanatos, since wild-type
fibroblasts die in a PARP-1-dependent but caspase-independent
fashion.
Identification of survival genes
To identify endogeneous brain protective genes, we generated a
retroviral cDNA expression library from primary cortical neurons
preconditioned with OGD and conducted a functional cloning
screen for protective molecules (Fig. 2). The mRNA for the library
was obtained from cortical neurons 16 h after a preconditioning
stimulus of 15 min of OGD, which leads to sustained and
profound protection against a subsequent lethal 90 min OGD
treatment (see Fig. 1A). The cDNA library from OGD
preconditioned cortical cultures with an average insert size of
2.5 Kb was cloned into the pFB retrovirus vector and virus was
generated. Primary mouse fibroblasts were infected with the
retrovirus and 48 h after infection the fibroblasts were challenged
with menadione (175 mM, 10 min) to induce parthanatos. Cells
that survived were grown another 9–13 days, and then re-
challenged with menadione to confirm cytoprotection and
eliminate false positives. 113 cell clones survived the initial
menadione treatment. Of these, 95 survived the menadione re-
challenge. The protective genes were recovered from the surviving
cell clones by PCR with oligonucleotide primers that recognize
regions flanking the multiple cloning site of the pFB vector (Fig. 2).
A total of 31 independent genes were recovered and sequenced
from the 95 cell clones (Table 1) Thirteen of the genes were
designated neuroprotective genes (NGP1 to NPG13) and the
sequences were deposited in the Genbank database. Accession
numbers are indicated in Table 1.
Functionally cloned genes are neuroprotective
Of the 31 genes recovered and sequenced, full open reading
frames were obtained for 28. To evaluate the neuroprotective
Figure 1. Preconditioning induces neuroprotection and menandione kills cells via Parthanatos. (A) 15 min of OGD preconditioning
induces neuroprotection 16 h and 24 h later against 90 min of lethal OGD. Primary cortical cultures were exposed to 90 min lethal OGD without
preconditioning (909 OGD) and compared to cultures exposed to 15 min of OGD and rechallenged with 90 min OGD 4 h, 6 h, 16 h and 24 h after the
15 min of OGD preconditioning. Cell viability was determined 24 h after 90 min lethal OGD by Hoescht 33342 (1 mg/ml) and prodidium iodide (7 mM)
staining and unbiased computer assisted cell counting [29]. (B). Menadione induces Parthanatos (PARP-1-dependent caspase-independent) fibroblast
death. Menadione (175 mM, 10 min) kills almost all of the wild type fibroblasts (WT) but only 55% or PARP-1 knockout fibroblasts (KO). Menadione
induced fibroblast death cannot be blocked by the caspase inhibitor, ZVAD (100 mM) or BAF (50 mM), which can blocks staurosporine (500 nM, 24 h)
induced cell death. Experiments were performed four times. Data are the mean 6 SEM. *p,0.01 (Student’s t-test) comparing OGD (90 min) against
OGD (15 min/90 min). An average number of 500,000 cells were counted.
doi:10.1371/journal.pone.0015008.g001
Figure 2. Functional cloning strategy. Diagram of the functional
cloning strategy utilized to identify neuroprotective genes (see text for
details).
doi:10.1371/journal.pone.0015008.g002
Neuroprotective Genes
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were subcloned into the multiple cloning site of the mammalian
expression vector, ADCGI. The vector is bicistronic vector, in
which the cytomegalovirus (CMV) promoter drives the enhanced
green fluorescent protein (EGFP) followed by an internal ribosome
entry site (IRES) followed by one of identified cloned genes. All the
other genes were cloned into the pCI expression vector and
primary cortical cultures were transiently transfected with
individual genes. When introducing genes into neurons with the
pCI vector, pCI-EGFP was co-transfected at ratio of 1:4 for pCI-
EGFP and the pCI-neuroprotective gene, respectively. Forty-eight
hours later, the neurons were treated with OGD (90 min) or
NMDA (500 mM, 5 min). Twenty-four hours after treatment, the
neurons were stained with Hoechst 33342 and propidium iodide.
Since only 1–2% of the cells in primary cortical cultures are
transfected, only EGFP positive cells were assessed for cell
viability. Dead neurons were scored as those cells that displayed
propidium iodide positive, condensed or fragmented nuclei (Fig. 3
A, B). All twenty-eight genes tested showed protective effects
against both OGD (90 min) (Fig. 4A) and NMDA (500 mM,
5 min) (Fig. 4B) toxicity with relatively similar efficacy. Full open
reading frames for three of the clones were not tested, and thus the
neuroprotective actions of Co III, NPG12 and NDB13 could not
be confirmed as neuroprotective genes.
Calmodulin and NPG2 participate in preconditioning
We next evaluated whether the neuroprotective genes identified
could be involved in the phenomena of preconditioning.
Calmodulin, a gene of known function, and NPG2, a gene of
unknown function, were selected for further characterization. In
primary cortical neurons exposed to the preconditioning stimulus
of 15 min OGD constitutively expressed calmodulin is upregu-
lated at both the mRNA and protein levels (Fig. 5A, B). Because
overexpression of calmodulin is neuroprotective against OGD and
Table 1. Cytoprotective Genes Identified by Functional Cloning.
Name Accession number # hits Function
c-Actin (cytoplasmic c-isoform of actin) X52815 1 cytoskeletal protein
Atlastin 1 (Atl1) NM_001009831 1 GTPase, vesicular transport
Bcl-xl U72350 2 anti-apoptosis
calcyon (Caly) NM_138915 3 Neuron-specific vesicular protein
Calmodulin (CaM, CALM2) NM_017326 3 Ca
2+ binding protein
CD151 antigen (Cd151) NM_022523 1 Tetraspanin
Choline Kinase b (Chkb) NM_017177 3 kinase, phosphocholine biosynthesis
Collapsin Response Mediator Protein-1 (CRMP1) NM_012932 1 neurite extension, axon guidance
Connective tissue growth factor (CTGF) NM_022266 1 growth factor
cytochrome c oxidase subunit Vb (Cox5b) NM_053586 3 energy production
Deoxyhypusine synthase (Dhps) NM_001004207 1 deoxyhypusine synthase
EH-domain containing 3 (Ehd3) NM_138890 3 endocytic recycling
Eukaryotic translation elongation factor 1 alpha 1 (Eef1a1) NM_175838 1 protein synthesis
Lactate dehydrogenase A (LDH-A) NM_017025 1 glycolytic enzyme
Mortality factor 4 like 2 (Morf4l2) NM_001007714 2 unknown
Ribosomal protein SA (Rpsa) NM_017138 2 unknown
tubulin, alpha 1A (Tuba1a) NM_022298 2 cytoskeletal protein
Neuroprotective Genes 1-11
NPG1, nucleolar protein family 6 (Nol6) EF688596 1 unknown
NPG2, ADP-ribosylation factor-like 4D, Arl4d EF688597 1 unknown
NPG3, lysine (K)-specific demethylase 1 (Kdm1) EF688598 3 histone demethylase
NPG4, MORN repeat containing 4 (Morn4) EF688599 1 unknown
NPG5, tetraspanin 7 (Tspan7) EF688600 1 tetraspanin
NPG6, ATPase family, AAA domain containing 1 (Atad1),
Thorase
EF688601 1 putative AAA+ ATPase
NPG7, ChaC, cation transport regulator homolog 1 (Chac1) EF688602 4 unknown
NPG8, ZW10 interactor (Zwint) EU000468 1 unknown
NPG9, COMM domain containing 9 (Commd9) EU000469 3 unknown
NPG10, microfibrillar-associated protein 3 (Mfap3) EU000470 1 unknown
NPG11, 60S ribosomal protein L13a (Rpl13a) EU000472 1 ribosomal subunit protein
Genes not tested
cytochrome c oxidase subunit III (Co III) M27315 3 energy production
NPG12, thrombospondin 2, (Thbs2) EU000471 1 secreted calcium-binding glycoprotein
NPG13, trans-2,3-enoyl-CoA reductase (Tecr) EU000473 1 unknown
doi:10.1371/journal.pone.0015008.t001
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up-regulation of calmodulin participates in the preconditioning
induced neuroprotection. RNAi to calmodulin was designed to
knock down the expression of calmodulin. Calmodulin RNAi was
introduced into HEK 293 cells and primary cortical neurons via
lipofectamine transfection. Knock down of calmodulin in HEK
293 cells was confirmed by immunoblot analysis (Fig. 5C)
Transfection with empty vector or an un-related RNAi (Lmr-1
RNAi) had no effect on calmodulin expression showing the
specificity of the RNAi to calmodulin (Fig. 5C). Efficacy of
knockdown of calmodulin via calmodulin RNAi in cortical
neurons was assessed via immunocytochemistry by co-transfecting
calmodulin RNAi with b-galactosidase (b-Gal) (Fig. 5D). In cells
expressing b-Gal, calmodulin expression is substantially reduced
(Fig. 5D). To analyze the effects of calmodulin knock down on the
protective effects of preconditioning, primary cortical neurons
were co-transfected with calmodulin RNAi and b-galactosidase
and compared to empty vector controls prior to the precondition-
ing exposure. 48 h later, the cells were preconditioned with OGD
(15 min) or NMDA (50 mM, 5 min) and 24 hr later the cultures
were exposed to a lethal treatment of OGD (90 min) or NMDA
(500 mM, 5 min), respectively. 24 h later, the cells were fixed and
stained with X-Gal and surviving neurons were scored as those
cells that displayed normal morphology. Knocking down calmod-
ulin expression by RNAi treatment during the preconditioning
phase is sufficient to block the survival of cortical neurons triggered
by OGD or NMDA preconditioning (Fig. 5E, F). These data
indicate that calmodulin is a potential important component in the
survival response activated by preconditioning.
Following exposure to 15 min OGD, NPG2 mRNA expression
is induced in primary cortical cultures (Fig. 6A). Four siRNAs to
NPG2 were tested for their efficacy in knocking down overex-
pressed NPG2 epitope tagged with myc at the N–terminus. HEK
293 cell cultures were transfected with the myc-tagged NPG2 in
the presences or absence of each of the NPG2 siRNAs. Three out
of four NPG2 siRNAs blocked myc-tagged NPG2 expression
(Fig. 6B). To test the efficacy of the NPG2 siRNAs to knock down
endogenous NPG2, Rat-2 cell cultures were transfected with each
of the siRNAs to NPG2 and knock down was assessed by
quantitative RT-PCR analysis. Of the four siRNAs, siRNA2
knocked down endogenous NPG2 (Fig. 6C). NPG2 siRNA2 was
used to knock down the induction of NPG2 in primary neurons in
response to the preconditioning stimulus of 15 min OGD or
50 mM NMDA for 5 min. NPG2 siRNA2 and pCI-EGFP were
co-transfected at ratio of 1:4 for pCI-EGFP and the NPG2
siRNA2, respectively. Scrambled siRNA was used as a control.
One day after the preconditioning event the cultures were exposed
to lethal OGD or NMDA and 24 hr later, the neurons were
stained with Hoechst 33342 and propidium iodide to assess cell
viability. Since only 1–2% of the cells in primary cortical cultures
are transfected, only EGFP positive cells were assessed for cell
viability. Dead neurons were scored as those cells that displayed
propidium iodide positive, condensed or fragmented nuclei
(Fig. 6D). NPG2 siRNA 2 is sufficient to prevent the neuronal
survival induced by OGD and NMDA preconditioning, but
scrambled siRNA had no effect (Fig. 6E). These results taken
together indicate that NPG2 is a neuroprotective gene that can
participate in preconditioning.
Discussion
Here we describe a functional cloning strategy to identify
neuroprotective genes. Thirty-one genes were cloned and
identified, and 28 full-length genes were recovered and confirmed
to be neuroprotective. This screening method will identify full
length genes in the library. It is not a comprehensive screening
Figure 3. Calmodulin overexpression protects against OGD and NMDA Excitotoxicity. (A and B) Representative photomicrographs of
cortical cultures transfected with empty vector or calmodulin and then exposed to (A) 90 min OGD or (B) 500 mM NMDA for 5 min. Cell death was
assessed 24 h later. Arrows or arrowheads indicate dead or surviving transfected neurons, respectively.
doi:10.1371/journal.pone.0015008.g003
Neuroprotective Genes
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functional cloning method has several advantages. Most of current
strategies for gene discovery are based on comparison of mRNA
changes [4,5,6,7,8,9]. Typically the initial screen reveals a very
large number, perhaps thousands of mRNA changes, following a
single biological manipulation. Most of these changes are not
causal to the subsequent phenomena being studied, such as
neuroprotection, but are a network response to the exposure of the
biologic system to the experimental conditions. It can be tedious to
sort through the non-specific response genes to find the critical
functional genes. The advantage of the functional screening
approach is that the method defines the identification of genes
involved in the biologic response of interest, in this case
neuroprotection. One of the limitations of the functional screening
approach is the size of the full-length inserts in a primary cDNA
library. Indeed the majority of the genes identified in this screen
were consistent with the average insert size of 2.5 Kb for the
library. Now that comprehensive full-length open reading frame
libraries are available, additional protective genes could be
identified using similar approaches. The power of functional
cloning for cytoprotective genes was confirmed by the identifica-
tion of 31 protective genes. All of the genes protected fibroblasts
against oxidative injury induced Parthanatos. Of the 31 genes
identified by the functional cloning method, 28 full-length genes
were recovered and all provide protection against OGD and
NMDA toxicity in primary cortical neurons. Similar studies could
be conducted in the future to identify genes that provide
protection against other activators of neuronal cell death.
The 31 identified genes fall into various functional categories.
Included in this gene set is the well-known protective gene, BCL-
xl, which validates the strategy [10]. Calmodulin plays important
role in neuronal survival [11]. CTGF promotes mesangial cell
survival [12]. Eukaryotic translation elongation factor 1 alpha 1
(Eaf1a1) protects against endoplasmic reticulum stress induced
apoptosis [13] and the closely related eEF1A2 may be linked to
neurodegeneration [14]. Deoxyhypusine synthase (Dhps) catalyzes
the first step in the post-translational modification of a lysine
residue in eukaryotic translation initiation factor 5A (eIF5A) to the
amino acid hypusine. Dhps may be linked to neuronal survival
through eIF5A, since the neuroprotective actions of nerve growth
factor are mediated by hypusinated eIF5A [15]. Inhibition of
choline kinase is linked to excitotoxic neuronal cell death [13].
Reduced expression of collapsin response mediator protein 1
(CRMP1) promotes the death of spinal cord neurons [16].
Neuroprotective gene 5 (NPG11), also known as thrombospondin
2 (Thbs2) is necessary for synaptic plasticity and functional
recovery after stroke [17]. Due to emerging importance of energy
metabolism in cell death and survival, genes such as cytochrome c
Figure 4. Functionally cloned genes are neuroprotective. (A and B). Primary cortical neurons were transfected with 28 of the identified genes
or the empty pCI vector or the ADCGI vector. EGFP serves as the reporter for transfected cells. 48 h later, the neurons were treated with (A) OGD
(90 min) or (B) NMDA (500 mM, 5 min). 24 h after treatment, neurons were stained with Hoechst 33342 and propidium iodide. Only EGFP positive
cells were scored. Dead neurons were scored as those cells that were propidium iodide positive, with condensed, or fragmented nuclei. Experiments
were performed at least three times. Data are the mean 6 SEM. *p,0.01 (Student’s t-test) comparing empty vector to each identified gene.
doi:10.1371/journal.pone.0015008.g004
Neuroprotective Genes
PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e15008oxidase subunits III and 5b, and lactate dehydrogenase A, are
likely to be protective through regulating neuronal energy
requirements and maintaining neurons in a bioenergenetically
favorable state [18,19].
Some of the identified genes are linked to neurological disease.
Atl1 encodes for the GTPase protein, atlastin. Mutations in Atl1,
also known as SPG3A cause autosomal dominant hereditary
spastic paraplegia [20]. Mutations in Tuba1 cause abnormal
neuronal migration in mice and lissencephaly in humans [21].
NPG5 encodes for a member of the tetraspanin family, tetraspanin
7 (TSPAN7) and mutations in TSPAN7 are linked to forms of X-
linked mental retardation in humans [22].
A number of genes without prior connections to survival
pathways were identified. Two cytoskeletal proteins, c-actin and
Tuba1a are neuroprotective. CD151 antigen (Cd151) and NPG5,
TPAN7 are members of the tetraspanins, which are expressed at
high levels in the plasma membrane or in intracellular vesicles. The
exact biologic role of tetraspanins is not clear but they may regulate
transient cell-to-cell or vesicular communication [23]. Calcyon
(Caly) is a neuron-specific vesicular protein that may regulate
dopamine receptor signaling [24]. EH-domain containing protein 3
(Ehd3) regulates early endosome to golgi transport [25]. Two
ribosomal subunit proteins were identified in the screen including
the 40S ribosomal protein SA (Rpsa) and NPG11, also known as
60S ribosomal protein L13a (Rpl13a). NPG3, also known as lysine
(K)-specific demethylase 1 (Kdm1) is a histone demethylase [26].
NPG6 isaputativeAAA+ ATPase,designatedATPasefamily,AAA
domain containing 1 (Atad1), which we have renamed Thorase.
NPG7 is also known as ChaC, cation transport regulator homolog 1
(Chac1). The Chac1 designation is probably a misnomer since
Figure 5. Calmodulin participates in preconditioning induced neuroprotection. Rat primary cortical neurons were treated with 15 min
OGD and harvested at the indicated time points for (A) Northern blot or (B) immunoblot analysis. b-actin and b-tubulin are the loading control for
Northern blot and immuonblot analysis, respectively. These experiments were conducted 3 times with similar results. (C) HEK 293 cells were
transfected with calmodulin RNAi, unrelated RNAi (Lmr-1 RNAi) or empty vector. Two days later Western blot of whole-cell extracts shows reduction
of calmodulin expression following calmodulin RNAi treatment but not Lmr-1 RNAi or empty vector. b–tubulin immunoreactivity was used as a
loading control. (D) Primary cortical neurons were transfected for 48 h with a control vector or calmodulin RNAi along with CMV-b-Gal. Overlay of the
anti-calmodulin and anti-b-Gal antibody staining. White arrows indicate transfected cells. (E and F) Primary cortical neurons were transfected with
empty vector or calmodulin RNAi. EGFP serves as the reporter for transfected cells. 48 h later, the cells were preconditioned with OGD (15 min) or
NMDA (50 mM, 5 min). 24 h after preconditioning, the cells were treated with OGD (90 min) or NMDA (500 mM, 5 min), respectively. 24 h after
treatment, neurons were stained with Hoechst 33342 and propidium iodide. Only EGFP positive cells were scored. Dead neurons were scored as
those cells that were propidium iodide positive, with condensed, or fragmented nuclei. (F) Quantification of cell viability. Experiments were
performed for three times, and the data was presented as mean 6 SEM. *p,0.001 (Student’s t-test) when comparing RNAi to empty vector.
doi:10.1371/journal.pone.0015008.g005
Neuroprotective Genes
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of the Cha operon. ChaA in bacteria regulates calcium and
hydrogen exchange [27], but there is no designated function for
ChaB and ChaC. Thus, further study is required to assign a
function to NPG7. NPG13, also known as trans-2-3-enoyl-CoA
reductase (Tecr) maybe involved in fatty acid elongation [28].
Many of the genes are genes of unknown function including
mortality factor 4 like 2 (Morf4l2), NPG1, also known as nucleolar
protein family 6 (Nol6), NPG2, also known as ADP-ribosylation
factor-like 4D (ARl4d), NPG4, also known as MORN repeat
containing 4 (Morn4), NPG8, also known as ZW10 interactor (Zwint),
NPG9, also known as COMM domain containing 9 (Commd9) and
NPG10, also known as NPG10, microfibrillar associated protein 3
(Mfap3). How each of the proteins of known function and unknown
function regulate cell survival will require further study, but the
diversity of proteins identified in this functional screen for protective
proteins indicates that there are many intrinsic cell survival pathways.
Since all the protective genes identified in this study derived
from a preconditioned library, we explored the role of two of the
genes in preconditioning induced neuronal survival. Knockdown
of either calmodulin or NPG2 eliminates the protection induced
by preconditioning. Whether any of the other protective genes
identified here play a role in preconditioning is not known and
requires further study. The fact that two seemingly unrelated genes
are sufficient for neuronal protection after preconditioning
suggests that there are either unrelated but essential pathways
for preconditioning induced neuronal survival or preconditioning
induced neuronal survival is due a complex set of co-induced
proteins, which are essential for the survival response. These data
suggest that there is a complex epistasis where multiple parallel
pathways are capable of producing a neuroprotective phenotype
with perhaps some convergent targets. As technology for genome-
wide detection of transcriptional targets becomes more robust, we
will be in a better position to address these points directly.
In summary, we have identified a broad range of genes that are
neuroprotective when overexpressed. For some genes identified
there are known biologic actions that would support a neuropro-
tective role. Most of the genes indentified here have, as of yet,
Figure 6. NPG2 participates in preconditioning induced neuroprotection. Primary cortical neurons were treated with 15 min OGD and
harvested at the indicated time for (A) Northern blot analysis. Lower panel shows loading of RNA. These experiments were conducted three times
with similar results. (B) HEK 293 cells were transfected with myc-tagged NPG2 and non-silencing control siRNA (nsRNA) or four different siRNA to
NPG2 (siRNA1-4). Western blots for anti-myc show siRNA 2-4 effectively knock-down NPG2 expression. b–tubulin immunoreactivity was used as a
loading control. (C) QT-PCR of Rat-2 cells transfected for 48 h with a control vector or siRNA to NPG2 shows that siRNA2 effectively knocks down
endogenous NPG2 transcript. (D and E) Primary cortical neurons were transfected with an empty vector or NPG2 siRNA along with EGFP. 48 h later,
the cells were preconditioned with OGD (15 min) or NMDA (50 mM, 5 min). 24 h after preconditioning, the cells were treated with OGD (90 min) or
NMDA (500 mM, 5 min), respectively. 24 h later, the cells were stained with Hoescht 33342 and propidium iodide. Only EGFP positive neurons were
scored. (D) Viable neurons were scored as those cells that displayed normal morphology. Dead neurons were scored as those cells that were
propidium iodide positive, with condensed, or fragmented nuclei. (E) Quantification of cell viability. Experiments were performed three times, and the
data was presented as mean 6 SEM. *p,0.001 (Student’s t test) when comparing siRNA to empty vector.
doi:10.1371/journal.pone.0015008.g006
Neuroprotective Genes
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study of these genes holds tremendous opportunity to identify
heretofore unexplored modes of neuronal survival and death and
offers opportunities for new neuroprotective strategies in the brain.
Materials and Methods
Ethics Statement
This study was performed in accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol for generation of primary
neuronal cultures was approved by the Johns Hopkins Animal Care
and Use Committee under protocol number MO09M136.
Primary Neuronal Cultures
Primary neuronal cortical cultures were generated as described
[29]. Briefly, embryonic day 16 rat cortex was dissected under a
microscope, exposed for 20 min to a 0.027% trypsin/saline
solution [5% PBS (in mM) 40 sucrose, 30 glucose, 10 HEPES,
pH 7.4], and then dissociated in modified Eagle’s medium
(MEM), 10% horse serum, 10% fetal bovine serum, and 2 mM
glutamine, by trituration. The cells were plated on 15 mm
multiwell plates (NUNC, Rochester, NY) coated with poly-
ornithine (Invitrogen, Carlsbad, CA) at a density of 3–4610
5 cells
per well. Four days after plating the cells were treated with 5-
fluoro-2-deoxyuridine (Sigma, St. Louis, MO) for three days to
inhibit proliferation of non-neuronal cells. Cultures were main-
tained in MEM, 5% horse serum, and 2 mM glutamine in 7%
CO2, in a humidified 37uC atmosphere. Mature neurons (12–14 d
in culture) were used for all experiments. In mature cultures,
neurons represent 70–90% of the total number of cells.
OGD Preconditioning and OGD Toxicity
Combined oxygen glucose deprivation (OGD) was performed in
mature cortical neurons as described [30] by complete exchange
with deoxygenated, glucose-free controlled salt solution (CSS)
containing: 120 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2,2 5m M
Tris-HCl, bubbled with 10% H2/85% N2/5% CO2. The cultures
were kept in an anaerobic chamber containing the gas mixture,
10% H2/85% N2/5% CO2, for 15 and/or 90 min at 37uC.
Combined OGD was terminated by replacement with oxygenated
growth media. Cell death assessments were performed 24 h after
the lethal 90 min OGD challenge.
NMDA Excitotoxicity
Neuronal cultures were exposed to 5 min of 500 mM NMDA
(Sigma, St. Louis, MO) with 10 mM glycine (Fisher, Pittsburgh,
PA) to induce excitotoxicity as described [29]. Exposure was
terminated by replacement with growth media. Cell death
assessments were performed 24 h later.
NMDA Preconditioning and Excitotoxicity
To induce preconditioning with NMDA the cells were exposed
to 5 min of 50 mM NMDA/10 mM glycine in CSS. The treatment
was terminated by wash and full exchange into growth media.
24 hr later the culture were exposed to 5 min of 500 mM NMDA/
10 mM glycine to induce excitotoxicity. Exposure was terminated
by replacement with growth media.
cDNA library
Rat primary cortical neurons were preconditioned with 15 min
OGD. 16 hours later, mRNA was isolated from the precondi-
tioned neurons with TRIzol reagent (Invitrogen, Carlsbad, CA)
per the manufacturers instructions. The isolated mRNA was used
to make double-strand cDNA using the SuperScript Kit (Invitro-
gen, Carlsbad, CA) per the manufacturers instruction. The cDNAs
were cloned into pFB retroviral vector per the manufacturers
instructions (Stratagene,La Jolla, CA).
Retrovirus production and fibroblast infection
Plasmids (3610
6) containing the OGD preconditioned cDNA
library were transfected into Phoenix amphopack 293 cells (Dr.
Garry Nolan, Stanford University) [31] with Lipofectamine 2000.
The cells were allowed to grow another 48 hours. The culture
media containing retrovirus was collected, filtered (0.45 mM filter
[Corning Incorporated, Lowell, MA]) and diluted 1:10 or 1:100 in
fibroblast growth media (Dulbecco’s modified Eagle’s medium
[DMEM], 10% fetal bovine serum) supplemented with polybrene
(8 mg/ml) (Sigma, St. Louis, MO). Fibroblasts were infected with
100 ml of retrovirus media that was added to mouse fibroblasts
plated at 800 cells/well of a 96 well plate (NUNC, Rochester, NY).
24 h later the culture media was fully exchanged with fibroblast
growth media. Fibroblasts were maintained in fibroblast growth
media, 7% CO2, humidified 37uC atmosphere.
Functional screening and recovery of cytoprotective
genes
48 h after retroviral infection of mouse fibroblasts, they were
treated with menadione (175 mM, 10 min). Surviving cells were
grown and amplified another 9–13 days. A fraction of these cells
were treated again with menadione to eliminate false positives. To
recover the cytoprotective genes, PCR with oligonucleotide
primers (Forward 59-GGC TGC CGA CCC CGG GGG TGG-
39, Reverse 59-CGA ACC CCA GAG TCC CGC TCA-39) that
recognize regions flanking the multiple cloning site of the pFB
vector was used to recover the cDNA from genomic DNA. The
PCR products were cloned into PCR-xl-TOPO cloning vector
(Invitrogen, Carlsbad, CA) by the method provided with the kit
and sequenced by the Genetic Core sequencing facility at the
Johns Hopkins University School of Medicine.
Cytotoxicity Assessment
Assessment of the protective effects of 15 min OGD precondi-
tioning against lethal 90 min OGD was performed by staining
with 1 mg/ml Hoechst (Sigma, St. Louis, MO) and 7 mM
propidium iodide (Sigma, St. Louis, MO) and unbiased computer
assisted cell counting [29]. Assessment of the potential protective
effects of the neuroprotective genes was performed by transfecting
primary cortical neurons with the identified gene or the empty
vector (pCI with EGFP). EGFP served as the reporter for
transfected cells. 48 h later, the neurons were treated with OGD
(90 min) or NMDA (500 mM, 5 min). 24 h after treatment,
neurons were stained with 1 mg/ml Hoechst 33342 and 7 mM
propidium iodide. Only EGFP positive cells were scored. Dead
neurons were scored as those cells that displayed PI positive,
condensed, or fragmented nuclei. At least three separate
experiments using 2 separate wells were performed for a minimum
of 100 neurons counted for each well. Fibroblast survival was
assessed 24 h after treatment and the viability was determined by
cell morphology. Live cells were scored as those displayed normal
morphology and dead fibroblasts were scored as those cells that
were shrunken and round in shape.
Expression Vectors and Transfection of Cultured Neurons
Expression vector pCI vector was used for the expression of
identified genes. The pCI vector (Promega, San Luis Obispo, CA)
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subset of the full-length genes were subcloned into the multiple
clone site of a mammalian expression vector (ADCGI vector). The
vector is bicistronic vector, which the cytomegalovirus (CMV)
promoter drives the enhanced green fluorescent protein (EGFP)
followed by internal ribosome entry site (IRES) promoter and then
followed by cloned gene. Primary cortical neurons were
maintained in culture for 12 days before transfection via
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to
manufacturer instructions. The PCI vector containing the gene of
interest was transfected at 0.8 mg/well together with pCI-EGFP at
0.2 mg/well per 24 well plate. 48 h after transfection, neurons
were challenged with either 90 min OGD or 500 mM NMDA.
Full Length Clones
Bcl-xl, Eef1a1, CD151 antigen, LDH-A, Cox5b, Tuba1 Chkb,
Calmodulin, Calcyon, Dhps, Morf4l2, Spg3a, Arf4l_predicted,
Rpsa, Tm4sf2, 531-7, 547-6 and Mfap3 full length clones were
obtained during the PCR recovery of neuroprotective genes and
were subsequently cloned into the pCI expression vector using the
multiple cloning site. Truncated forms of all the other genes were
obtained during the PCR recovery and such full-length mouse, rat
or human clones were purchased for further study. Mouse CRMP1,
rat Rpl13a, mouse Nol6, mouse CTGF, rat Zwint-1, mouse AOF2
full-length clones were obtained from Open Biosystems, Alabama,
and were cloned in pCI vector for expression. Homo sapiens Ehd3
was obtained from Dr. David N. Louis, Harvard Medical School
[32], and was cloned in pCI vector for expression. The rat 697-27
full-length clone was obtained by screening of full-length library
[32] with the truncated 697-27 PCR probe, and it was cloned into
the pCI vector for expression.
Northern Blot Analysis
Total RNA (10 mg) was separated on 1% agarose gels
containing 2.2 M formaldehyde, transferred to a nylon membrane
(Hybond-XL, Amersham, Piscataway, NJ) and fixed. Probes were
made from cDNA sequences and labeled with a-
32P dATP using a
random primer labeling kit (Amersham, Piscataway, NJ). Mem-
branes hybridized washed and were exposed to a PhosphorImager
plate for 1 day. The bands were visualized and quantified using a
PhosphorImager (Molecular Dynamics, Sunnyvale, CA). The blots
were stripped and rehybridized with a
32P-labeled mouse b-actin
probe to assess RNA loading efficiency.
RNAi and siRNA
Two complementary short oligo DNA (forward 59-CCC TGA
ATT TCT GAC AAT GTT CAA GAG ACA TTG TCA GAA
ATT CAG GGT TTT TT-39 and reverse 59-AAT TAA AAA
ACC CTG AAT TTC TGA CAA TGT CTC TTG AAC ATT
GTC AGA AAT TCA GGG GGCC-39) were synthesized
according to the calmodulin sequence. Double stranded DNA
was made by denaturing at 95uC for 5 min then renaturing at
37uC for 1 hr. The double stranded DNA was cloned into the
gene silencer vector (Ambion, Austin, TX).
siRNA. Four Arf4l siRNAs (siRNA1: sense 59-GACUGGAG-
ACAUAUGUAAAdTdT-39 and antisense 59-UUUACAUAUG-
UCUCCAGUCdTdT-39; siRNA2: sense 59-GGAAGACUUCC-
CUUCUUUAdTdT-39 and antisense 59-UAAAGAAGGGAAG-
UCUUCCdCdG-39; siRNA3: sense 59-AGACUGGAGACAUA-
UGUAAdTdT-39 and antisense 59-UUACAUAUGUCUCCAG-
UCUdTdG-39; siRNA4: sense 59-GCCUCAAGUUCAAGGAA-
UUdTdT-39 and antisense 59-AAUUCCUUGAACUUGAGGC-
dGdG-39) and scramble control siRNA (sense 59-UUCUCCGA-
ACGUGUCACGUdTdT-39 and antisense 59-ACGUGACAC-
GUUCGGAGAAdTdT-39) were ordered from Qiagen (Valencia,
CA). siRNAs were introduced into cells with GeneSilencer
transfection reagent (Gene Therapy Systems, San Diego, CA) or
lipofectamine transfection reagent (Invitrogen, Carlsbad, CA).
Immunoblotting
Cell cultures following the different treatment paradigms were
collected in 100 ml of Tris HCl buffer (pH 7.4) containing 2 mM
EDTA, 1 mM b-mercaptoethanol, 1 mM PMSF, 1 mM benza-
mide and leupeptin (10 ml/ml). Equal protein was loaded per lane
into a 12% polyacrylyamide gel. After electrophoresis and
nitrocellulose membrane (Bio-Rad, Hercules, CA) transfer, the
membranes were incubated overnight with antibodies. The
primary antibody (anti-calmodulin, Abcam, Cambridge, MA;
anti-myc) were diluted 1:1000 in 5% dry nonfat milk, 0.1%
Tween-20 in phosphate buffer (pH 7.4). Subsequently, nitrocellu-
lose membranes were incubated for 3 hr with secondary antibody
(1:5000) (Pierce, Rockford, IL) at room temperature in 5% non-fat
dry milk in phosphate buffer (pH 7.4). The labeled bands were
visualized using chemiluminescence (Pierce, Rockford, IL).
Immunohistochemistry
Cells were washed with PBS and fixed in fresh 4%
paraformaldehyde at 4uC for 1 hr, then blocked with 4% normal
goat serum (Abcam, Cambridge, MA) in PBS for 30 min at room
temperature. Antibody (LacZ antibody was from Sigma, St. Louis,
MO; Calmodulin antibody was from Abcam, Cambridge, MA)
was applied for 12–16 hr at 4uC. After two 10 min wishes with
PBS, cultures were incubated in fluorescent FITC or rhodamine
conjugated secondary antibody (Abcam, Cambridge, MA) for 1 hr
at room temperature, and then washed again with PBS as before.
The cultures were incubated with nucleus staining dye TOTO-3
(1:1000) (Applied Biosystems, Foster City, CA) for 10 min at room
temperature, and then washed twice (5 min) with PBS.
siRNA
Four Arf4l siRNAs (siRNA1: sense 59-GAC UGG AGA CAU
AUG UAAAdTdT-39 and antisense 59-UUU ACA UAU GUC
UCC AGUCdTdT-39; siRNA2: sense 59-GGA AGA CUU CCC
UUC UUUAdTdT-39 and antisense 59-UAA AGA AGG GAA
GUC UUC CdCdG-39; siRNA3: sense 59-AGA CUG GAG ACA
UAU GUAAdTdT-39 and antisense 59-UUA CAU AUG UCU
CCA GUC UdTdG-39; siRNA4: sense 59-GCC UCA AGU UCA
AGG AAU UdTdT-39 and antisense 59-AAU UCC UUG AAC
UUG AGG CdGdG-39) and non-silencing control siRNA (sense
59-UUC UCC GAA CGU GUC ACGUdTdT-39 and antisense
59-ACG UGA CAC GUU CGG AGAAdTdT-39) were ordered
from Qiagen (Valencia, CA).
Quantitative RT-PCR
10 ng total RNA was assayed by quantitative RT-PCR with one
step QuantiTect SYBR Green RT-PCR Kit (Qiagen, Valencia,
CA) on an ABI 7900HT real-time PCR machine. Reaction was
performed in a 20 mL reaction mixture consisting of 10 mL2 6
QuantiTect SYBR Green, 10 ng RNA, 0.2 mL QuantiTect RT
mix and 0.6 mmol/L of each primer. NPG2 (forward 59-AAG
GAC TGA GGG AGC ATA-39 and reverse 59-.TAG GTG AAG
GGC AGT GAA GA-39). Reverse transcription was performed at
50uC for 30 min. Quantitative RT-PCR was run for 40 cycles
(94uC for 15 sec, 55uC for 30 sec, and 72uC for an additional
30 sec) following a hot start (95uC for 10 min). Melting curves
were obtained by increasing the temperature from 55uCt o9 6 uC
in increments of 0.5uC and samples were examined for the
Neuroprotective Genes
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determining the cycle threshold (Ct) and triplicate qRT-PCR
reactions were done for each mRNA samples. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as the reference
gene.
Statistical Analysis
For all quantitative data, significant overall F values were
obtained by using a one-way, between-groups analysis of variance
(ANOVA). Specific comparison on all possible pair wise
combinations were made with the Student’s t-test for independent
means. Significance was determined at p,0.05.
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